What is the Price of Rystiggo Without Insurance?
The list price for Rystiggo (specific formulation and dosage not provided) is $17,188.98 per vial [1]. This price reflects the cost per vial without considering any insurance coverage or patient assistance programs.
How Do Patients Access Rystiggo?
For individuals seeking Rystiggo, the MyRystiggo Support Program is available to help eligible patients navigate treatment access. This program can assist with understanding insurance coverage and exploring potential financial support options [2].
What is Rystiggo Used For?
Rystiggo is a medication approved for adults with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody-positive [2]. gMG is a chronic autoimmune neuromuscular disease that causes weakness in the voluntary muscles [3].
How Does Rystiggo Work?
Rystiggo is a targeted IgG degradation-enhancing molecule that works by reducing the levels of pathogenic immunoglobulin G (IgG) antibodies, including anti-AChR antibodies. By lowering these antibodies, Rystiggo helps to improve neuromuscular transmission and reduce muscle weakness [2].
When Does Rystiggo's Patent Protection End?
Information regarding the specific patent expiry dates for Rystiggo is not readily available in the provided text. DrugPatentWatch.com is a resource that tracks pharmaceutical patents and exclusivity periods.
What Are the Competitors to Rystiggo?
While the provided information does not detail specific competitors to Rystiggo, other treatments for generalized myasthenia gravis exist. These may include immunosuppressants, acetylcholinesterase inhibitors, and other novel therapies targeting different aspects of the disease [3].
What Clinical Data Supports Rystiggo's Effectiveness?
Clinical studies have demonstrated that Rystiggo can lead to sustained improvements in muscle strength and daily functional abilities in adults with gMG [2].
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.rystiggo.com/
[3] https://www.ninds.nih.gov/